<DOC>
	<DOC>NCT00575601</DOC>
	<brief_summary>The purpose of this study is to determine whether simvastatin is effective in the improvement of IVF-ICSI outcome in Pcos patients.</brief_summary>
	<brief_title>Effects of Simvastatin on Biochemical Parameters and Outcome of IVF-ICSI in Pcos Patients</brief_title>
	<detailed_description>simvastatin reduces cardiovascular risks by improving hypercholesterolemia, reducing vascular smooth muscle proliferation, ameliorating inflammation, limiting theca-interstitial proliferation &amp; decreasing steroidogenesis (production of progesterone &amp; testosterone).Polycystic ovary syndrome (pcos) is associated with increased cardiovascular risks and is characterized by ovarian theca-interstitial hyperplasia&amp; hyperandrogenism .This study will test the hypothesis that simvastatin improves biochemical parameters&amp; IVF-ICSI outcome in Pcos patients.</detailed_description>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Pcos patients Age &lt;40 years FSH&lt;10 IU/L Endometriosis grade 3 &amp;4 History of tubal surgery Hydrosalpinx History of mellitis diabetes</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>pco</keyword>
	<keyword>simvastatin</keyword>
	<keyword>ivf</keyword>
	<keyword>embryo transfer</keyword>
</DOC>